- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Photon-Counting Takes on MBIS and Tomosynthesis Products at RSNA 2011
Philips will highlight its newly released MicroDose Mammography System at RSNA 2011. The Philips unit will go head to head with other new entries in the mammography space including Hologic’s 3-D breast tomosynthesis product, Selenia® Dimensions, whole breast ultrasound from U-Systems, Dilon’s 6800 MBI scanner, and GE’s Discovery MB750b, a molecular breast imaging system.
Philips will highlight its newly released MicroDose Mammography System at RSNA 2011.
The Philips unit will go head to head at RSNA with other new entries in the mammography space including Hologic’s 3-D breast tomosynthesis product, Selenia® Dimensions (previewed at RSNA in 2010 and FDA approved in February 2011), whole breast ultrasound from U-Systems, Dilon’s 6800 MBI scanner, and GE’s Discovery MB750b, a molecular breast imaging system.
Philips’ system is the first in the US to use photon-counting technology, designed to improve clarity while reducing dose. Photon counting reduces the number of intermediate conversion steps needed to create a digital signal. Each conversion can reduce image quality. The MicroDose system delivers no ghost images and a 50 µm pixel size at 100 percent pixel accuracy, according to Kim Holttum, senior director of global marketing, Women’s Health Care, Philips Healthcare. The field of view is 24 by 26 cm.
Plus, the dose is about half that of full-field digital mammography (FFDM) systems, Holttum says. Automatic exposure control (AEC) can adjust dose based on breast density.
The units also are fast. With no wait time between acquisitions, exams take only 4 minutes, making it possible to do 12 to 18 exams an hour, Holttum estimates. That’s good for patients, technologists, and the bottom line.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.
